Education
About Us
Working with TipRanks
Follow Us
Proteomics International Laboratories Ltd. (AU:PIQ)
ASX:PIQ
Total Valuation
Proteomics International Laboratories Ltd. has a market cap or net worth of AU$62.77M. The enterprise value is AU$51.18M.
Market CapAU$62.77M
Enterprise ValueAU$51.18M
Share Statistics
Proteomics International Laboratories Ltd. has 165,184,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding165,184,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Proteomics International Laboratories Ltd.’s return on equity (ROE) is -0.62 and return on invested capital (ROIC) is -78.70%.
Return on Equity (ROE)-0.62
Return on Assets (ROA)-0.55
Return on Invested Capital (ROIC)-78.70%
Return on Capital Employed (ROCE)-0.80
Revenue Per Employee10.00T>
Profits Per Employee―
Employee Count―
Asset Turnover0.06
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Proteomics International Laboratories Ltd. is ―. Proteomics International Laboratories Ltd.’s PEG ratio is -0.84.
PE Ratio―
PS Ratio50.61
PB Ratio3.69
Price to Fair Value3.69
Price to FCF-7.33
Price to Operating Cash Flow-6.76
PEG Ratio-0.84
Income Statement
In the last 12 months, Proteomics International Laboratories Ltd. had revenue of 960.39K and earned -8.11M in profits. Earnings per share was -0.05.
Revenue960.39K
Gross Profit960.39K
Operating Income-10.62M
Pretax Income-8.15M
Net Income-8.11M
EBITDA-10.00M
Earnings Per Share (EPS)-0.05
Cash Flow
In the last 12 months, operating cash flow was -6.60M and capital expenditures -29.65K, giving a free cash flow of -6.63M billion.
Operating Cash Flow-6.60M
Free Cash Flow-6.63M
Free Cash Flow per Share-0.04
Dividends & Yields
Proteomics International Laboratories Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.35
52-Week Price Change-35.34%
50-Day Moving Average0.56
200-Day Moving Average0.41
Relative Strength Index (RSI)28.56
Average Volume (3m)426.90K
Important Dates
Proteomics International Laboratories Ltd. upcoming earnings date is Mar 4, 2026, TBA (Confirmed).
Last Earnings DateAug 26, 2025
Next Earnings DateMar 4, 2026
Ex-Dividend Date―
Financial Position
Proteomics International Laboratories Ltd. as a current ratio of 9.39, with Debt / Equity ratio of 2.11%
Current Ratio9.39
Quick Ratio9.39
Debt to Market Cap0.00
Net Debt to EBITDA1.08
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Proteomics International Laboratories Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Proteomics International Laboratories Ltd. EV to EBITDA ratio is -3.79, with an EV/FCF ratio of -5.70.
EV to Sales39.40
EV to EBITDA-3.79
EV to Free Cash Flow-5.70
EV to Operating Cash Flow-5.73
Balance Sheet
Proteomics International Laboratories Ltd. has AU$11.04M in cash and marketable securities with AU$277.74K in debt, giving a net cash position of AU$10.76M billion.
Cash & Marketable SecuritiesAU$11.04M
Total DebtAU$277.74K
Net CashAU$10.76M
Net Cash Per ShareAU$0.07
Tangible Book Value Per ShareAU$0.09
Margins
Gross margin is -453.01%, with operating margin of -1105.67%, and net profit margin of -844.95%.
Gross Margin-453.01%
Operating Margin-1105.67%
Pretax Margin-849.08%
Net Profit Margin-844.95%
EBITDA Margin-1040.83%
EBIT Margin-1105.67%
Analyst Forecast
The average price target for Proteomics International Laboratories Ltd. is AU$0.43, which is 11.43% higher than the current price. The consensus rating is Moderate Sell
Price TargetAU$0.43
Price Target Upside-35.82% Downside
Analyst ConsensusModerate Sell
Analyst Count1
Revenue Growth Forecast7.65%
EPS Growth Forecast-19.13%